% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-11}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1005.

\begin{enumerate}[leftmargin=*]
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. Biomolecules. [published; Crossref]. \href{https://doi.org/10.3390/biom16070983}{doi:10.3390/biom16070983}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Koning E, Richard J, Keshen A. (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.}. International Journal of Eating Disorders. [published; Europe PMC]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y. (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar (2026). \textit{Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review}. Journal of Affective Disorders Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.jadr.2026.101098}{doi:10.1016/j.jadr.2026.101098}.
\item Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD. (2026). \textit{Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0255}{doi:10.1001/jamapsychiatry.2026.0255}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S (2026). \textit{Psychedelics as a potential treatment for borderline personality disorder: A narrative review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2026.117152}{doi:10.1016/j.psychres.2026.117152}.
\item Sjöström D, Schau Rybäck O, Claesdotter Knutsson E, Kajonius P, Jensen Sondén O, Carlbring P, Björkstrand J, Movahed Rad P. (2026). \textit{Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0352246}{doi:10.1371/journal.pone.0352246}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT. (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Özaydın Y, Canlan Özaydın B. (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item Flavia Giaffone de Paiva Ferreira, João Ariel Bonar Fernandes, Renato Filev, Dartiu Xavier da Silveira, Thiago Marques Fidalgo (2026). \textit{The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261453850}{doi:10.1177/02698811261453850}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Guidetti C, Fava M, Papakostas GI. (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Camille Racca, Cécilie Cordier (2026). \textit{Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1}{doi:10.17504/protocols.io.j8nlk7ey6g5r/v1}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin (2026). \textit{Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review}. CNS Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40263-026-01305-9}{doi:10.1007/s40263-026-01305-9}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA}. SAIMSARA Journal. [published; OpenAlex]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; OpenAlex]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item Lucas Cruz, Fernando R. Beserra, Julia M.K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi (2026). \textit{Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review}. Journal of Clinical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1002/jclp.70167}{doi:10.1002/jclp.70167}.
\item Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček (2026). \textit{Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00514}{doi:10.1556/2054.2026.00514}.
\item Helerin Raikkerus, Andrea Bujour, Mark Kennedy, Jari Tiihonen (2026). \textit{The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2026.10088}{doi:10.1017/neu.2026.10088}.
\item Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians}. Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Genís Oña, Cristina Llagostera, Oscar Alvarez, Rosa M. Dueñas, Débora González, Óscar Soto-Angona (2026). \textit{Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy}. Natural Product Research. [published; OpenAlex]. \href{https://doi.org/10.1080/14786419.2026.2683121}{doi:10.1080/14786419.2026.2683121}.
\item Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal (2026). \textit{From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2026.11141}{doi:10.1192/bjo.2026.11141}.
\item Matthew Sidovar, Shane J. O’Connor, Lucinda Orsini (2026). \textit{EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2026.03.422}{doi:10.1016/j.jval.2026.03.422}.
\item T. Rowe, T. Hurzeler, E. Towers, E. Louie, K. C. Morley (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Anna Beatriz Vicentini, Caio Cesar de Paula, José Augusto Silva Reis, José Carlos Bouso, Jaime E. C. Hallak, Rafael G. dos Santos (2026). \textit{Classic psychedelics and personality: An updated systematic review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Alex Hood, Gary ELKINS (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Elliot Hampsey, Kirsty Martin, Michail Kalfas, Louis Benson, Sirid Wihlborg, Luke Jelen, Allan H. Young, James Rucker (2026). \textit{A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261453938}{doi:10.1177/02698811261453938}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M. (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item Unknown authors (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Caleb Lemus (2026). \textit{Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713\&context=dmscjournal}{source link}.
\item Jamarie Geller, Rachel Pacilio, Amanda E. Downey, Anya Ragnhildstveit, Marissa Raymond-Flesch, Stephanie Knatz-Peck, Natalie Gukasyan (2026). \textit{Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care}. Current Psychiatry Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s11920-026-01679-z}{doi:10.1007/s11920-026-01679-z}.
\item Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; OpenAlex]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item Ioanna Artemis Vamvakopoulou, D. P. Nicholls, David J. Nutt, M. Di Simplicio (2026). \textit{Exploring new avenues: Psychedelic-assisted therapy for young people}. British Journal of Clinical Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1002/bcp.70579}{doi:10.1002/bcp.70579}.
\item Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Joshua Poulin, Nic Viulet, Ashley Liu, Bradley J. MacIntosh, Sean M. Nestor (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Low ZXB. (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Deivid Antonio Cahuasqui-Mendoza (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; OpenAlex]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; OpenAlex]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; OpenAlex]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions}. Current Issues in Molecular Biology. [published; OpenAlex]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin’s Kinematic Effect on Manual Dexterity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9291780/v1}{doi:10.21203/rs.3.rs-9291780/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item S. Parker Singleton, Brooke L. Sevchik, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon Vandekar, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item Shakila Meshkat, Manish K. Jha, Venkat Bhat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Kush V. Bhatt, Joseph Friedman, Lindsay Benster, Rekha Narasimhan, Ke Yang, Jyoti Mishra, Cory R. Weissman, Dhakshin Ramanathan (2026). \textit{Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use}. Community Mental Health Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10597-026-01620-x}{doi:10.1007/s10597-026-01620-x}.
\item Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Yves Martins Varela, Vagner Deuel de O Tavares, Luiza Macedo Delgado, Heitor Augusto Trindade de Faria, Lucas Queiroz Menezes, R. Z. H. Almeida, Pedro Moraes Dutra Agrícola, Bruna Santos de Carvalho, Bheatrix Bienemann, Marcelo Falchi-Carvalho, Patrícia Cavalcanti-Ribeiro, Fernanda Palhano-Fontes, Gisele Fernandes-Osterhold, Dráulio Barros de Araújo, Nicole Leite Galvão-Coelho (2026). \textit{Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-025-02188-5}{doi:10.1007/s00406-025-02188-5}.
\item Ana Cláudia Mesquita Garcia, Geovanna Maria Isidoro, Cremilson de Paula Silva (2026). \textit{Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2026.03.012}{doi:10.1016/j.jpainsymman.2026.03.012}.
\item Piotr Skalski, Katarzyna Pękacka-Falkowska, Agnieszka Pluto-Prądzyńska, Michał K. Owecki (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)}. Brain Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Shivaputra A. Patil, Holly C. Hunsberger (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations}. Expert Opinion on Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Gillet A, Geron C, Vitello MM, Lejeune N. (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Malkanthi Evans, Andrew Charrette (2026). \textit{Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1816932}{doi:10.3389/fnins.2026.1816932}.
\item Denis Nößler (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; OpenAlex]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item Bonnie Brusky, Katia M’Baïlara, François Alla, M. Barrault (2026). \textit{Psychological support in psychedelic-assisted therapy clinical trials: A systematic review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261424204}{doi:10.1177/02698811261424204}.
\item Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Àlvar Farré-Colomés, Olga Rublinetska, Óscar Soto-Angona (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Georgia Chlebek (2026). \textit{Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies}. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). [published; OpenAlex]. \href{https://ir.library.louisville.edu/tce/vol3/iss1/11}{source link}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Marc-Antoine Crocq, Philippe Auby (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology}. Child and Adolescent Psychiatry and Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, Mickael Eskinazi, Kerem Böge, Stefan Leucht, Federico Seragnoli, Leonice Furtado, Tatiana Aboulafia Brakha, Logos Curtis, Matthias Kirschner, Stefan Kaiser, Louise Penzenstadler, Daniele Zullino, Mikkel Højlund, Jade Gallo, Marco Solmi, Jacopo Sapienza, Marta Bosia, Joseph La Torre (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review}. Schizophrenia Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Unknown authors (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1080/02791072.2025.2454474.}{doi:10.1080/02791072.2025.2454474.}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Jennifer E. Thomas, Anna Dellarole, Joshua Caballero (2026). \textit{Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review}. American Journal of Health-System Pharmacy. [published; OpenAlex]. \href{https://doi.org/10.1093/ajhp/zxag062}{doi:10.1093/ajhp/zxag062}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA (2026). \textit{Meaning and Psychedelics in Palliative Care: A Narrative Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2025.10.015}{doi:10.1016/j.jpainsymman.2025.10.015}.
\item Mosurinjohn S, Ascough R (2026). \textit{Psychedelics, Eleusis, and the Invention of Religious Experience.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251361835}{doi:10.1177/28314425251361835}.
\item Rosalind McAlpine, Magdalena Jaglinska, Krisztina Jedlovszky, Joanna Kuc, Ariel Castro, Alexandre Piot, Christopher Timmermann, Jeremy I Skipper, Matthew D Sacchet, Sunjeev K. Kamboj (2026). \textit{Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2025-107512}{doi:10.1136/bmjopen-2025-107512}.
\item Ovie Martin Albert, Alexander Arthur (2026). \textit{Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling}. Therapeutic Advances in Drug Safety. [published; OpenAlex]. \href{https://doi.org/10.1177/20420986261436104}{doi:10.1177/20420986261436104}.
\item C Faria, Diana Dias da Silva, João José Sousa (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7173}{doi:10.26537/prpaeh.v4i3.7173}.
\item Linda M. Richmond (2026). \textit{MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2026.03.3.5}{doi:10.1176/appi.pn.2026.03.3.5}.
\item Shokr MM, Fawzy MN, Abdelaziz AM. (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations}. Psychiatry and Clinical Neurosciences. [published; OpenAlex]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Momoko Ishii, Mark Zervas (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A. (2026). \textit{Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251364182}{doi:10.1177/28314425251364182}.
\item Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep M. Nayak, David B Yaden (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Luca Magnani, Luca Ghirotto, Fabio Fesce, Tania Simona Re, Silvia Tanzi, Andrea Amerio, Alessandra Costanza (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review}. BMJ Supportive \& Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Marten Kase, Kristjan Kaup, Jaan Aru (2026). \textit{Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251412012}{doi:10.1177/02698811251412012}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Chiranth Bhagavan, Olivia P. Carter, Alexander Bryson, Orwa Dandash, Richard Kanaan (2026). \textit{Psychedelics in functional disorders: A scoping review}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111642}{doi:10.1016/j.pnpbp.2026.111642}.
\item Alexa Camarena-Michel, John Michael Rague (2026). \textit{Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature}. Current Opinion in Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cotox.2026.100574}{doi:10.1016/j.cotox.2026.100574}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Tianyi Xu, Sabrina Wong, Gia Han Le, Christine E. Dri, Kayla M. Teopiz, Andy Lu, Serene M. L. Lee, Taeho Greg Rhee, Liyang Yin, Stavroula I. Bargiota, Roger Ho, Roger S. McIntyre (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Lukasz Siwek, Marta Nowocien, Barbara Balajewicz, Angelika Samborska, Sara Szukalska, Marta Karczewska, Karolina Lichwala, Kamil Wroblewski, Paulina Wróblewska (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra (2026). \textit{Psychedelic research and sexuality: opportunities and pitfalls}. The Journal of Sexual Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/jsxmed/qdag025}{doi:10.1093/jsxmed/qdag025}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Rayyan Raja Zafar, Patrick Kleine, Danielle L. Kurtin, Matthew B. Wall, David Erritzoe (2026). \textit{High hopes? Precision psychedelic addiction medicine}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1681795}{doi:10.3389/fpsyt.2025.1681795}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item S Shiju, Rohan P. Tirumala, Elliot Marseille (2026). \textit{Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence}. Exploratory Research in Clinical and Social Pharmacy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.rcsop.2026.100709}{doi:10.1016/j.rcsop.2026.100709}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Omer A. Syed, Benjamin Tsang, Sean M. Nestor, Nir Lipsman, Muhammad Ishrat Husain, Fahad Alam, Peter Giacobbe (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/94398}{doi:10.48620/94398}.
\item Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker, Polina Catzeflis, Alexander Wopfner, Niklaus Denier, Tobias Bracht, Kristina Adorjan, Mario Pfammatter, Felix Müller, Leila Maria Soravia (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2025.54843}{doi:10.1001/jamanetworkopen.2025.54843}.
\item Maria Garcia Garcia, Dahbia Belahda, Carine Graux, Chris Serrand, Noe Igounenc, Felix Sergent, Thibault Mura, Amandine Luquiens (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis}. BMC Psychology. [published; OpenAlex]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate (2025). \textit{Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/yu3n9}{doi:10.17605/osf.io/yu3n9}.
\item Jorge Oliveira (2025). \textit{Psilocybin-Assisted Therapy for Mood Disorders: A Comparative Literature Review of Australia, the United States, the United Kingdom, and Canada}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.13140/rg.2.2.35623.10402}{doi:10.13140/rg.2.2.35623.10402}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2025). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Jensen, Hailey A (2025). \textit{Psilocybin Treatment for Refractory Depression: A Clinical Review}. Digital Commons - Gardner-Webb University (Gardner-Webb University). [published; OpenAlex]. \href{https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63}{source link}.
\item Viljoen G, Betzler F (2025). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin (2025). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin}. Human Psychopharmacology Clinical and Experimental. [published; OpenAlex]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Tyler Durns, Greg Iannuzzi (2025). \textit{Contextualizing Violence Risk Associated With Hallucinogens}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.20250027}{doi:10.1176/appi.focus.20250027}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2025). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Monika Dominiak, Adam Gędek, Szymon Modrzejewski, Agnieszka Permoda-Osip, Anna Zofia Antosik (2025). \textit{Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials}. Journal of Clinical Medicine. [published; OpenAlex]. \href{https://doi.org/10.3390/jcm15010253}{doi:10.3390/jcm15010253}.
\item Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail (2025). \textit{A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder}. Current Treatment Options in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1007/s40501-025-00373-w}{doi:10.1007/s40501-025-00373-w}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2025). \textit{A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2025.12.22.25342874}{doi:10.64898/2025.12.22.25342874}.
\item Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S. (2025). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Tewin Tencomnao, Siriporn Chuchawankul (2025). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Pedro Rodrigues, Weliton Rodrigues dos Santos Júnior, Ivan de Sousa Araújo, Leonardo Maia Leony, Fernanda Adélia Almeida Custódio Pires Gomes, Tairone Matos de Lima Junior, Luís Felipe Freitas Moreira, Rafael Telles Santana, Manoel Carlos Matos Santos, R. Silva (2025). \textit{COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55905/edicon.978-65-83115-47-8\_8}{doi:10.55905/edicon.978-65-83115-47-8\_8}.
\item Samuel Hosford, Heather Austin-Robillard (2025). \textit{Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency}. Contemporary Family Therapy. [published; OpenAlex]. \href{https://doi.org/10.1007/s10591-025-09766-8}{doi:10.1007/s10591-025-09766-8}.
\item Justin Dwyer, Robert B. Johnston, Clare O’Callaghan, Margaret Ross (2025). \textit{Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.002}{doi:10.1016/j.genhosppsych.2025.12.002}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag.2}{doi:10.32388/xcfsag.2}.
\item Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger (2025). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS. (2025). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS. (2025). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F. (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Machado T, Rodrigues ASL, Costa J. (2025). \textit{Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251397590}{doi:10.1177/20451253251397590}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Johannes Klaus, Fritz Schneider, Rena Schaletzky, Daniel Sippel, Anil Batra (2025). \textit{Psychedelics for the Treatment of Substance Use Disorders}. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1024/0939-5911/a000953}{doi:10.1024/0939-5911/a000953}.
\item Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen (2025). \textit{Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects}. Tidsskrift for Norsk psykologforening. [published; OpenAlex]. \href{https://doi.org/10.52734/hgsn7664}{doi:10.52734/hgsn7664}.
\item Netta Pinhas, Nofar Eidlman, Avigail Barnea, Leehe Peled-Avron (2025). \textit{Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2025.106493}{doi:10.1016/j.neubiorev.2025.106493}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M. (2025). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell (2025). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251394012}{doi:10.1177/28314425251394012}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag}{doi:10.32388/xcfsag}.
\item Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item Zhang W, Hwang SY, Luther J. (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item William Roseby, Catriona Osborn Moar (2025). \textit{A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040041}{doi:10.3390/psychoactives4040041}.
\item Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, A ZHAO, Katrin H. Preller, Robin Carhart-Harris, Morten L. Kringelbach (2025). \textit{Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03731-7}{doi:10.1038/s41398-025-03731-7}.
\item Presley Aspen, Presley Pham, Jennifer Mitchell (2025). \textit{Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes}. Berkeley Scientific Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/bs329265627}{doi:10.5070/bs329265627}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M. (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP. (2025). \textit{Psilocybin and chronic neuropathic pain: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/rapm-2024-105532}{doi:10.1136/rapm-2024-105532}.
\item Kent E. Hutchison, Jake F. Hooper, Hollis C. Karoly (2025). \textit{Psilocybin Outside the Clinic}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2025.3038}{doi:10.1001/jamapsychiatry.2025.3038}.
\item Srivastava AB, Gold MS (2025). \textit{A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15111190}{doi:10.3390/brainsci15111190}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. (2025). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir (2025). \textit{Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025i.0044}{doi:10.61373/pp025i.0044}.
\item Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. (2025). \textit{A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare13212668}{doi:10.3390/healthcare13212668}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P. (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Uyar A, Forbrich L, Lueken U, Evens R. (2025). \textit{Landscape analysis of pre-registered clinical trials involving classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251371690}{doi:10.1177/02698811251371690}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC. (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202510.1355.v1}{doi:10.20944/preprints202510.1355.v1}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item David J. Heal, Jane Gosden, Sharon L. Smith (2025). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Moskovitz M (2025). \textit{The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00583}{doi:10.1021/acsptsci.5c00583}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD. (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Kevin Murnane (2025). \textit{A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899594}{source link}.
\item Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P (2025). \textit{Harm reduction practises for users of psychedelic drugs: a scoping review.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01264-2}{doi:10.1186/s12954-025-01264-2}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2352-4642(25)00208-1}{doi:10.1016/s2352-4642(25)00208-1}.
\item Caporuscio C, Poppe C, Gieselmann A, Repantis D. (2025). \textit{Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291725101761}{doi:10.1017/s0033291725101761}.
\item Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti (2025). \textit{Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review}. Clinical Neuropsychopharmacology and Addiction. [published; OpenAlex]. \href{https://doi.org/10.53941/cna.2025.100006}{doi:10.53941/cna.2025.100006}.
\item Matthew Halma, R. Levy, Joseph Varón (2025). \textit{With great power comes great responsibility: Promise and caution in the new psychedelic renaissance}. Brain Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dscb.2025.100286}{doi:10.1016/j.dscb.2025.100286}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V. (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Beaglehole B, Manuel J. (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C (2025). \textit{Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses}. ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley). [published; OpenAlex]. \href{https://scholarworks.utrgv.edu/colloquium/2025/talks/1}{source link}.
\item Maastricht University (2025). \textit{The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06368492}{source link}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS. (2025). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Ariane Bélanger, Sue-Ling Chang, Jean-François Stephan, Florence Moureaux, Diane Tapp, Robert Foxman, Pierre Gagnon, Johanne Hébert, Houman Farzin, Michel Dorval (2025). \textit{Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy}. Healthcare. [published; OpenAlex]. \href{https://doi.org/10.3390/healthcare13182290}{doi:10.3390/healthcare13182290}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA. (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Georgios Mikellides, Marios Kyriazis (2025). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item Jaime Moreno-Chaparro, Gabriela Castañeda-Millán, Javier Eslava-Schmalbach (2025). \textit{Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review}. Clinical Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/wnf.0000000000000653}{doi:10.1097/wnf.0000000000000653}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Bilenker D, Avena NM. (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Garcia ACM, Maia LO. (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi (2025). \textit{Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent}. Psychopharmacology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.64719/pb.4525}{doi:10.64719/pb.4525}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A. (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Im JJH, Sandoe CH (2025). \textit{Psychedelics and Headache Disorders: an Update.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-025-01446-2}{doi:10.1007/s11910-025-01446-2}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG. (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Between enhancement and risk: A critical review of psychedelic microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copsyc.2025.102129}{doi:10.1016/j.copsyc.2025.102129}.
\item Miller M, Meyers M, Krainak K, Lewis SP. (2025). \textit{Interventions to support spirituality among adults with cancer: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00520-025-09787-x}{doi:10.1007/s00520-025-09787-x}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M (2025). \textit{Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2025.104604}{doi:10.1016/j.ajp.2025.104604}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A. (2025). \textit{Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40519-025-01771-y}{doi:10.1007/s40519-025-01771-y}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Rudy LM, Godlewski MM. (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI. (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Katherine Cheung, Caleigh Propes, Marianna Graziosi, Kyle Patch, David B. Yaden (2025). \textit{Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis}. AJOB Empirical Bioethics. [published; OpenAlex]. \href{https://doi.org/10.1080/23294515.2025.2526339}{doi:10.1080/23294515.2025.2526339}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR. (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Damian Świeczkowski, Aleksander Kwaśny, Patrycja Ciurkowska, Michał Pruc, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251353250}{doi:10.1177/02698811251353250}.
\item Glenn DL, Choi SH, Zimmerman RS. (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL. (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Jens Larsen, Pernille Kølbæk, Søren Dinesen Østergaard (2025). \textit{Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases}. Nordic Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1080/08039488.2025.2529449}{doi:10.1080/08039488.2025.2529449}.
\item Khaleel Rajwani, Melanie Almonte, F. Feroz, Jamila Hokanson, Edward Jacobs, Julian Savulescu, Ilina Singh, David B. Yaden, Brian D. Earp (2025). \textit{Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies}. Wellcome Open Research. [published; OpenAlex]. \href{https://doi.org/10.12688/wellcomeopenres.24181.1}{doi:10.12688/wellcomeopenres.24181.1}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S. (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Mark Haden, Sarah A. Paschall, Birgitta Woods (2025). \textit{Beyond prohibition: A public health analysis of naturalistic psychedelic use}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00450}{doi:10.1556/2054.2025.00450}.
\item Priya Chaudhary, Pracheta Janmeda (2025). \textit{Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and Medicines}. Current Bioactive Compounds. [published; OpenAlex]. \href{https://doi.org/10.2174/0115734072383313250602052217}{doi:10.2174/0115734072383313250602052217}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Beneš M, Páleníček T, Horáček J. (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM. (2025). \textit{Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18070989}{doi:10.3390/ph18070989}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J. (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Samuel E Christen, Elias Bekka, Yasmin Schmid, Neal L. Benowitz, Evangelia Liakoni (2025). \textit{Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances}. Swiss Medical Weekly. [published; OpenAlex]. \href{https://doi.org/10.57187/s.4346}{doi:10.57187/s.4346}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE. (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu (2025). \textit{Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism}. Magna Scientia Advanced Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.30574/msarr.2025.14.1.0079}{doi:10.30574/msarr.2025.14.1.0079}.
\item Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ. (2025). \textit{A Scoping Review of Research in Naturalistic Studies with Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2520221}{doi:10.1080/02791072.2025.2520221}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S. (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Vinarcsik L, Smoller C, Grossberg G. (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J. (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R. (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Menge J, Evitt B. (2025). \textit{Pharmacologic interventions for alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/01.jaa.0000000000000106}{doi:10.1097/01.jaa.0000000000000106}.
\item Stéphanie Knatz Peck, Timothy D. Brewerton, Hannah M. Fisher, Julie Trim, Samantha Shao, Nadav Liam Modlin, Jessie Kim, Daphna M. Finn, Walter H. Kaye (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Palmer C, Ferber AT, Greenwald BD. (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR. (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Morris R, Keeler J, Treasure J, Himmerich H. (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Estric C, Duron T, Kabani S, Lopez-Castroman J. (2025). \textit{Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338214}{doi:10.1177/02698811251338214}.
\item Syed OA, Petranker R, Tsang B. (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD. (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B. (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A (2025). \textit{The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106086}{doi:10.1016/j.neubiorev.2025.106086}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Saara Susan Sevander, Marja-Liisa Rissanen (2025). \textit{The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.59476/hesdia.v0i1.700}{doi:10.59476/hesdia.v0i1.700}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis}. The International Journal of Psychiatry in Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD. (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Godfrey K, Luan LX, Timmermann C. (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item Mimms C, Sotelo K, Khaliq AS. (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V. (2025). \textit{Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106163}{doi:10.1016/j.neubiorev.2025.106163}.
\item Turizo Smith AD, Botero Jsramillo N, Berrio Cuartas DM. (2025). \textit{Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202504.0888.v1}{doi:10.20944/preprints202504.0888.v1}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A. (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D. (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio (2025). \textit{Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.393}{doi:10.1192/j.eurpsy.2025.393}.
\item A. Oliveira-Maia (2025). \textit{Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.64}{doi:10.1192/j.eurpsy.2025.64}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001113}{doi:10.1097/njh.0000000000001113}.
\item Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Thomson S, Thomacos N. (2025). \textit{Utilizing Psychedelics to Enhance Well-Being: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2484380}{doi:10.1080/02791072.2025.2484380}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Bires J. (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V. (2025). \textit{Pharmacokinetics of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/pharmaceutics17040411}{doi:10.3390/pharmaceutics17040411}.
\item Serretti A. (2025). \textit{Anhedonia: Current and future treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item M. Cirillo (2025). \textit{Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678251321040}{doi:10.1177/00221678251321040}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY. (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item McMaster University (2025). \textit{An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06225232}{source link}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L. (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Dino F. (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Valentin Yurievich Skryabin (2025). \textit{The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?}. Neurology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.17816/nb639991}{doi:10.17816/nb639991}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Galdino TP, Oliveira LC, Luz MA, Jesus RA, Lima EPN, Torres MCM, Sivieri K, Afonso VI, Delgado JMPQ, Lima AGB, Silva SML, Fook MVL. (2025). \textit{Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18030380}{doi:10.3390/ph18030380}.
\item Modzelewski S, Stankiewicz A, Waszkiewicz N, Łukasiewicz K. (2025). \textit{Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110402}{doi:10.1016/j.neuropharm.2025.110402}.
\item Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff (2025). \textit{Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2025.200301}{doi:10.1176/appi.ajp-rj.2025.200301}.
\item Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska (2025). \textit{Risks of using psilocybin in treatment of treatment-resistant depression}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2025.79.58319}{doi:10.12775/jehs.2025.79.58319}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-025-01487-3}{doi:10.1007/s40262-025-01487-3}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME. (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P. (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V. (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D. (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Ahuja S, Zaher F, Palaniyappan L. (2025). \textit{Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251319455}{doi:10.1177/02698811251319455}.
\item Fábio Nogueira Pereira, Ana Carina Rothechedl Cavalieri, João Paulo Crespo Ferreira, Kelly De Souza Ventura (2025). \textit{Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted Psychotherapy}. Polymatheia.. [published; OpenAlex]. \href{https://doi.org/10.52521/poly.v18i1.14945}{doi:10.52521/poly.v18i1.14945}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Unknown authors (2025). \textit{CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.r111}{doi:10.1136/bmj.r111}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T. (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J. (2025). \textit{Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16762}{doi:10.1111/add.16762}.
\item Kargbo RB. (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Kurzbaum E, Páleníček T, Shrchaton A, Azerrad S, Dekel Y. (2025). \textit{Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof11020099}{doi:10.3390/jof11020099}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S. (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Ganguly A, James M, Alici Y (2025). \textit{When death is desired: A case of MAiD \& the CL psychiatrist.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524002037}{doi:10.1017/s1478951524002037}.
\item Liebnau J, Betzler F, Kerber A. (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M. (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A. (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA. (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-024-01454-4}{doi:10.1007/s40262-024-01454-4}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM. (2025). \textit{Social pain: A systematic review on interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J. (2025). \textit{A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116359}{doi:10.1016/j.psychres.2025.116359}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J. (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Tuğcan MO, Akpınar AA. (2025). \textit{Mushroom poisoning: An updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole (2024). \textit{Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/ar2s4}{doi:10.17605/osf.io/ar2s4}.
\item Maud, Kaitlin (2024). \textit{Use Cases for Art Therapy Intervention in Clinical Psychedelic Praxis}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.25768866.v2}{doi:10.6084/m9.figshare.25768866.v2}.
\item Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro (2024). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Mile Jevtić (2024). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2024). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Ramaekers JG, Reckweg JT, Mason NL. (2024). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM. (2024). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Wijesekara T, Xu B. (2024). \textit{Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/09603271251323134}{doi:10.1177/09603271251323134}.
\item Cumming P, Egger K, Knudsen GM (2024). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves, Fabiano A. Gomes, Elisa Brietzke (2024). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Trends in Psychiatry and Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E. (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2024). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R. (2024). \textit{ALSUntangled \#77: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Geller J, Whitney E. (2024). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE. (2024). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/njh.0000000000001096}{doi:10.1097/njh.0000000000001096}.
\item Ferreira AE, Reis-Pina P. (2024). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB. (2024). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Schonholz SM, Appel JM, Bursztajn HJ, Nair M, MacIntyre MR. (2024). \textit{Legal and Ethics Concerns of Psilocybin as Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.29158/jaapl.240089-24}{doi:10.29158/jaapl.240089-24}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A. (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM. (2024). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ. (2024). \textit{Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(24)00333-x}{doi:10.1016/s2215-0366(24)00333-x}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Terao I, Kodama W. (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item Menon V, Ramamurthy P, Venu S, Andrade C. (2024). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Piercey CJ, Gray B, Sung A, Henry D, Karoly HC. (2024). \textit{Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0052}{doi:10.1089/psymed.2023.0052}.
\item George Tewfik, Adejuyigbe Adaralegbe, Sangel Gomez, Rania Aziz, Faraz Chaudhry, Daniel Rodriguez-Correa, Dorisanne O. Adaralegbe (2024). \textit{Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications}. Trends in Anaesthesia and Critical Care. [published; OpenAlex]. \href{https://doi.org/10.1016/j.tacc.2024.101514}{doi:10.1016/j.tacc.2024.101514}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB. (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Collins HM. (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A. (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Calder AE, Hase A, Hasler G. (2024). \textit{Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02830-z}{doi:10.1038/s41380-024-02830-z}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M. (2024). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item Miller CE, Zoladz PR. (2024). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Kargbo RB. (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Kargbo RB. (2024). \textit{Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00521}{doi:10.1021/acsmedchemlett.4c00521}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Barstowe A, Kajonius PJ. (2024). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Unknown authors (2024). \textit{Review of trials finds psychedelics generally well-tolerated}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31244}{doi:10.1002/pu.31244}.
\item Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph17111484}{doi:10.3390/ph17111484}.
\item Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari (2024). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT. (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-74810-w}{doi:10.1038/s41598-024-74810-w}.
\item Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202410.1406.v1}{doi:10.20944/preprints202410.1406.v1}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Imperio CG, Levin FR, Martinez D. (2024). \textit{The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20231023}{doi:10.1176/appi.ajp.20231023}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Unknown authors (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen, Albert Dahan (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar (2024). \textit{Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3040029}{doi:10.3390/psychoactives3040029}.
\item Junges LH, Müller-Santos M. (2024). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D (2024). \textit{Artificial intelligence and psychedelic medicine.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15229}{doi:10.1111/nyas.15229}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V. (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Unknown authors (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D. (2024). \textit{Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.3459}{doi:10.1002/cpt.3459}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C. (2024). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Vamvakopoulou IA, Nutt DJ. (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W. (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item Gobbi G. (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Werle I, Bertoglio LJ. (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Danielle B Rodrigues (2024). \textit{Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials}. Journal of Complementary Medicine \& Alternative Healthcare. [published; OpenAlex]. \href{https://doi.org/10.19080/jcmah.2024.13.555852}{doi:10.19080/jcmah.2024.13.555852}.
\item Spoelstra SK, Schoevers RA, Venema SD, Knegtering H. (2024). \textit{Psychedelics as a potential treatment for tobacco use disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s44192-024-00095-0}{doi:10.1007/s44192-024-00095-0}.
\item Savides IA, Outhoff K. (2024). \textit{Less is more? A review of psilocybin microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241278769}{doi:10.1177/02698811241278769}.
\item Li G, Facchini PJ. (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C. (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O. (2024). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y. (2024). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Anna Graue, Sören Kuitunen-Paul, Henry G. Harder, Lisa Emily Richter (2024). \textit{Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0044-1790396}{doi:10.1055/s-0044-1790396}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Loizaga-Velder A, Loizaga Pazzi A. (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Jungwirth J, Bavato F, Quednow BB. (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Najib J. (2024). \textit{The role of psilocybin in depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Lodetti G, de Bitencourt RM, Rico EP. (2024). \textit{Classic psychedelics and the treatment for alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111129}{doi:10.1016/j.pnpbp.2024.111129}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS. (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M. (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S. (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS. (2024). \textit{The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1439347}{doi:10.3389/fpsyt.2024.1439347}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A. (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Michael P. Bogenschutz (2024). \textit{A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16647}{doi:10.1111/add.16647}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF. (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Ashley Glowiak (2024). \textit{Resurrecting Ancestral Familial Health: A Role for Psilocybin?}. The Family Journal. [published; OpenAlex]. \href{https://doi.org/10.1177/10664807241269505}{doi:10.1177/10664807241269505}.
\item Yang X, Kuang W. (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Unknown authors (2024). \textit{Precipitous Increases in Psilocybin Exposure in Youths}. AAP Grand Rounds. [published; OpenAlex]. \href{https://doi.org/10.1542/gr.52-2-19}{doi:10.1542/gr.52-2-19}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item Kaiserman A, Vanderjist L, Kornreich C. (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item V Suresh, Jitendra Lakhani, R Balaraman (2024). \textit{Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients}. Journal of Natural Remedies. [published; OpenAlex]. \href{https://doi.org/10.18311/jnr/2024/35676}{doi:10.18311/jnr/2024/35676}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A. (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item Liam Engel, Sascha Thal, Stephen Bright, Mitchell Low (2024). \textit{Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00377}{doi:10.1556/2054.2024.00377}.
\item Ahuja S, Zaher F, Palaniyappan L. (2024). \textit{Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4534997/v1}{doi:10.21203/rs.3.rs-4534997/v1}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek (2024). \textit{Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence}. Current Psychopharmacologye. [published; OpenAlex]. \href{https://doi.org/10.2174/0122115560288779240628043307}{doi:10.2174/0122115560288779240628043307}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item DeBattista C, Schatzberg AF. (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y. (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Unknown authors (2024). \textit{Review identifies factors associated with response to psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31193}{doi:10.1002/pu.31193}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Guo Q, Guo L, Wang Y, Shang S. (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item Torrado Pacheco A, Moghaddam B. (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J. (2024). \textit{A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0051}{doi:10.1089/psymed.2023.0051}.
\item P. Todd Korthuis, Adrianne R. Wilson-Poe, Joshua C. Black, Andrew A. Monte (2024). \textit{Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16589}{doi:10.1111/add.16589}.
\item Polito V, Liknaitzky P. (2024). \textit{Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241254831}{doi:10.1177/02698811241254831}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Ramos L, Vicente SG. (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM. (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD. (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Unknown authors (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB. (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X. (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item S Morris (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient}. Clinical Psychopharmacology and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E, Greenshaw A, Li XM, Milne M, Wang F, Cao B, Winship IR, Zhang Y, Chan AW. (2024). \textit{Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1386321}{doi:10.3389/fpsyt.2024.1386321}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Stephen N. Xenakis, Scott Shannon (2024). \textit{What is needed for the roll-out of psychedelic treatments?}. Current Opinion in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1097/yco.0000000000000946}{doi:10.1097/yco.0000000000000946}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.02.592231}{doi:10.1101/2024.05.02.592231}.
\item British Medical Journal Publishing Group (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Hanna Brancaccio (2024). \textit{Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}.
\item Prince Patel, Samrat Gollapudi, Brian Joseph Mathew, Bhaumik B. Patel (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2024). \textit{Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115880}{doi:10.1016/j.psychres.2024.115880}.
\item Metaxa AM, Clarke M. (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL. (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Val Bellman (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon}. Cancers. [published; OpenAlex]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M. (2024). \textit{Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01005-z}{doi:10.1186/s40337-024-01005-z}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Köhne S, Hillemacher T, Glahn A, Bach P. (2024). \textit{Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2024.2342951}{doi:10.1080/14728214.2024.2342951}.
\item Rahman SM, Salem Y, Hussain A. (2024). \textit{Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/derm.2023.0292}{doi:10.1089/derm.2023.0292}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item Hatfield SP, Thornton NL, Greenstien K, Glozier N. (2024). \textit{A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241240597}{doi:10.1177/00048674241240597}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. (2024). \textit{[Psychedelic psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38572715}{source link}.
\item J. S. Seo (2024). \textit{Current situation regarding psychedelics and magic mushroom in Korea}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1695}{doi:10.1192/j.eurpsy.2024.1695}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y. (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item Terri D’Arrigo (2024). \textit{MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.1}{doi:10.1176/appi.pn.2024.04.4.1}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Velit-Salazar MR, Shiroma PR, Cherian E. (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Christopher L. Robinson, Alexandra Fonseca, Efemena Diejomaoh, Ryan S. D’Souza, Michael E Schatman, Vwaire Orhurhu, Trent Emerick (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain}. Journal of Pain Research. [published; OpenAlex]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Kush Bhatt, Cory R. Weissman (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Agor D, Knettel BA, Daici K, Meanley S. (2024). \textit{The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cnur.2024.01.005}{doi:10.1016/j.cnur.2024.01.005}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ. (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Fang S, Yang X, Zhang W. (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Dong L, Li L, Wu Y, Zhao X, Zhong H, Cheng X, Liu L, Cheng C, Ouyang M, Tao L. (2024). \textit{A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12529-024-10262-w}{doi:10.1007/s12529-024-10262-w}.
\item Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM (2024). \textit{The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2023.2296968}{doi:10.1080/03007995.2023.2296968}.
\item Holze F, Singh N, Liechti ME, D'Souza DC. (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V. (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS. (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item David F. Lo, Hasan Zia, Pranetha Rajkumar, Adarsh Thakur, Heather O’Donnell (2024). \textit{Modern Psychedelic Microdosing Research on Mental Health}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.23r03581}{doi:10.4088/pcc.23r03581}.
\item Rouaud A, Calder AE, Hasler G. (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi (2024). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Barajas, Carlos (2023). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item Sebastiaan Werten (2023). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 2; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.80786.r276698}{doi:10.5256/f1000research.80786.r276698}.
\item Manoj K. Doss (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 2 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96124}{doi:10.21956/wellcomeopenres.24838.r96124}.
\item Rayyan Zafar (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96127}{doi:10.21956/wellcomeopenres.24838.r96127}.
\item Manesh Girn (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r93854}{doi:10.21956/wellcomeopenres.24838.r93854}.
\item Lorenzo Pasquini (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r95501}{doi:10.21956/wellcomeopenres.24838.r95501}.
\item Tessa Watford (2023). \textit{The Therapeutic Potential of Psilocybin for Depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.33548/scientia1082}{doi:10.33548/scientia1082}.
\item Unknown authors (2023). \textit{Psilocybin may be as effective as escitalopram in treating depression, study suggests}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.327949}{doi:10.1211/pj.2024.1.327949}.
\item Rakesh Khanna (2023). \textit{Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?}. Journal of Indira Gandhi Institute Of Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.4103/jigims.jigims\_60\_23}{doi:10.4103/jigims.jigims\_60\_23}.
\item Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A (2023). \textit{IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106998}{doi:10.1016/j.phrs.2023.106998}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. (2023). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P (2023). \textit{Keeping the promise: a critique of the current state of microdosing research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1217102}{doi:10.3389/fpsyt.2024.1217102}.
\item Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś (2023). \textit{Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.50.01.005}{doi:10.12775/jehs.2023.50.01.005}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Brennan W, Kelman AR, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0007}{doi:10.1089/psymed.2023.0007}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM. (2023). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Tahlia R. Harrison (2023). \textit{Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00267}{doi:10.1556/2054.2023.00267}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item Hovmand OR, Poulsen ED, Arnfred S. (2023). \textit{Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231200019}{doi:10.1177/02698811231200019}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G. (2023). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Wolinsky D, Barrett FS, Vandrey R. (2023). \textit{The psychedelic effects of cannabis: A review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A. (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ. (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Van Der Walt J, Parker R. (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST. (2023). \textit{Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drudis.2023.103818}{doi:10.1016/j.drudis.2023.103818}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Kaminski D, Reinert JP. (2023). \textit{The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280231205645}{doi:10.1177/10600280231205645}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Unknown authors (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Wsół A. (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Watford T, Masood N. (2023). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, Eickhoff CR, Eickhoff SB, Edwards RR, Larsen B, McKinstry-Wu A, Scott JC, Roalf DR, Sharma V, Strain EC, Corder G, Dworkin RH, Satterthwaite TD. (2023). \textit{Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105421}{doi:10.1016/j.neubiorev.2023.105421}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Akhila Yerubandi, Joshua Caballero (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Wolfgang AS, Hoge CW. (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Syed OA, Tsang B, Gerlai R. (2023). \textit{The zebrafish for preclinical psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Zoë Dubus, Élise Grandgeorge, Vincent Verroust (2023). \textit{History of the administration of psychedelics in France}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2023.1131565}{doi:10.3389/fpsyg.2023.1131565}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP. (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Emmanuelle A. D. Schindler, Peter S. Hendricks (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders}. Expert Review of Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ. (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI. (2023). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. International Journal of Mental Health Nursing. [published; OpenAlex]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH (2023). \textit{use of psilocybin in the treatment of psychiatric disorders - review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.43.01.009}{doi:10.12775/jehs.2023.43.01.009}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Schindler EAD. (2023). \textit{The Potential of Psychedelics for the Treatment of Episodic Migraine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-023-01145-y}{doi:10.1007/s11916-023-01145-y}.
\item Jing X, Hoeh NR, Menkes DB. (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Ibrahim IB, Videbech P, Straszek SPV. (2023). \textit{Psychedelic drugs in the treatment of psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37615227}{source link}.
\item Terri D’Arrigo (2023). \textit{Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.08.8.3}{doi:10.1176/appi.pn.2023.08.8.3}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB. (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Bhanot S, Lin M, Bains S, Monroe A, Tsang V. (2023). \textit{A systematic review to assess the use of psilocybin in the treatment of headaches}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660046}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Zeiss R. (2023). \textit{Psilocybin as an antidepressant strategy - a review of safety aspects}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10405689}{source link}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Unknown authors (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1089/psymed.2023.00071}{doi:10.1089/psymed.2023.00071}.
\item Brennan B, Kelman A, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2ab59}{doi:10.31234/osf.io/2ab59}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Unknown authors (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Scott R. Walker, Glenn A. Pullella, Matthew Piggott, Peter J. Duggan (2023). \textit{Introduction to the chemistry and pharmacology of psychedelic drugs}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23050}{doi:10.1071/ch23050}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ. (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA. (2023). \textit{Psilocybin's effects on cognition and creativity: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231179801}{doi:10.1177/02698811231179801}.
\item Kozak Z, Johnson MW, Aaronson ST. (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza, Gustavo A. Angarita (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G. (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Kevin Herkenham (2023). \textit{A regulatory framework review of Schedule I psychedelics in the United States}. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. [published; OpenAlex]. \href{https://doi.org/10.1002/jac5.1841}{doi:10.1002/jac5.1841}.
\item Koning E, Brietzke E. (2023). \textit{Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47626/2237-6089-2022-0597}{doi:10.47626/2237-6089-2022-0597}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND608043020}{source link}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Evens R, Schmidt ME, Majić T, Schmidt TT. (2023). \textit{The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253231172254}{doi:10.1177/20451253231172254}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE. (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Fonseka LN, Woo BK. (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A. (2023). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Meyer M, Slot J. (2023). \textit{The evolution and ecology of psilocybin in nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.heliyon.2023.e16338}{doi:10.1016/j.heliyon.2023.e16338}.
\item Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta (2023). \textit{Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2022-068884}{doi:10.1136/bmjopen-2022-068884}.
\item Dunn Harmony, Freeman Judy, Michael John Dochniak (2023). \textit{Psilocybin-Based Breakthroughs in Natural Medicine}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1021}{doi:10.33425/2693-1516.1021}.
\item Dunn Harmony, Freeman Judy, D Michael (2023). \textit{Psilocybin-based mushrooms and usage}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1022}{doi:10.33425/2693-1516.1022}.
\item Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico, Jeffrey Eilbott, Anastasia Jankovsky, Michelle Burke, Jamila Hokanson, Brad Martins, Chelsea Witherow, Prerana Patel, Lucia Amoroso, Henry Schaer, Christopher Pittenger, Benjamin Kelmendi (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S. (2023). \textit{Psilocybin in Palliative Care: An Update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13670-023-00383-7}{doi:10.1007/s13670-023-00383-7}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A. (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Wang Y, Sun H, Ji Q, Wei J, Zhu P. (2023). \textit{Systematic Review of Interventions for Demoralization in Patients With Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/nmd.0000000000001615}{doi:10.1097/nmd.0000000000001615}.
\item Dawood Hristova JJ, Pérez-Jover V. (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Domanegg K, Sommer WH, Meinhardt MW. (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Sharma R, Batchelor R, Sin J. (2023). \textit{Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2190319}{doi:10.1080/02791072.2023.2190319}.
\item Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS. (2023). \textit{Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1123424}{doi:10.3389/fpsyt.2023.1123424}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Daniel A Kinderlehrer (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study}. International Medical Case Reports Journal. [published; OpenAlex]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Stephanie Karzon Abrams, Brenden Samuel Rabinovitch, Rayyan Zafar, Aly Shah Aziz, Nicholas P. Cherup, David W. McMillan, Jessica L. Nielson, Evan Lewis (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics}. Neurotrauma Reports. [published; OpenAlex]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Jacob S. Aday, Zachary Skiles, Noa Eaton, Lisa Fredenburg, Mollie Pleet, Jessica Mantia, Ellen Bradley, Gisele Fernandes-Osterhold, Joshua Woolley (2023). \textit{Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0004}{doi:10.1089/psymed.2022.0004}.
\item Crowe M, Manuel J, Carlyle D, Lacey C. (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Jeffery Heilman (2023). \textit{The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy}. Journal of Scientific Exploration. [published; OpenAlex]. \href{https://doi.org/10.31275/20222633}{doi:10.31275/20222633}.
\item van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A. (2023). \textit{Therapeutic effect of psilocybin in addiction: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1134454}{doi:10.3389/fpsyt.2023.1134454}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P. (2023). \textit{Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph20031870}{doi:10.3390/ijerph20031870}.
\item Keith Heinzerling (2023). \textit{Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04410913}{source link}.
\item Pedicini M, Cordner ZA. (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item White CM, Weisman N, Dalo J. (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Capaldi JM, Shabanian J, Finster LB, Asher A, Wertheimer JC, Zebrack BJ, Shirazipour CH. (2023). \textit{Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17437199.2022.2162947}{doi:10.1080/17437199.2022.2162947}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI. (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Baker KM, Ulrich CM, Meghani SH. (2023). \textit{An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10499091221147700}{doi:10.1177/10499091221147700}.
\item Andersen S. (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f26ce}{doi:10.31234/osf.io/f26ce}.
\item Unknown authors (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item John R. Rossiter (2022). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Ezeaka UC, Kim HJJ, Laprairie RB. (2022). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item Rivera-García MT, Cruz SL. (2022). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau (2022). \textit{Efficacy and Safety of Psychedelics in Treating Anxiety Disorders}. Ochsner Journal. [published; OpenAlex]. \href{https://doi.org/10.31486/toj.23.0076}{doi:10.31486/toj.23.0076}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2022). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I. (2022). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37387703}{source link}.
\item Urban MM, Stingl MR, Meinhardt MW (2022). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Phan AN, Terry GE (2022). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2022). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2022). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF (2022). \textit{"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201263}{doi:10.1080/02791072.2023.2201263}.
\item Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC (2022). \textit{Psychedelics, epilepsy, and seizures: a review.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1326815}{doi:10.3389/fphar.2023.1326815}.
\item Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S (2022). \textit{A Review of Synthetic Access to Therapeutic Compounds Extracted from.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010040}{doi:10.3390/ph16010040}.
\item Meccia J, Lopez J, Bagot RC. (2022). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. (2022). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Joshua S. Siegel, James E. Daily, Demetrius A. Perry, Ginger E. Nicol (2022). \textit{Psychedelic Drug Legislative Reform and Legalization in the US}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2022.4101}{doi:10.1001/jamapsychiatry.2022.4101}.
\item Lee HJ, Stein MB. (2022). \textit{Update on treatments for anxiety-related disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Passie T, Guss J, Krähenmann R. (2022). \textit{Lower-dose psycholytic therapy - A neglected approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1020505}{doi:10.3389/fpsyt.2022.1020505}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item MacCallum CA, Lo LA, Pistawka CA, Deol JK. (2022). \textit{Therapeutic use of psilocybin: Practical considerations for dosing and administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1040217}{doi:10.3389/fpsyt.2022.1040217}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. (2022). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Dupuis D, Veissière S. (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A. (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. (2022). \textit{Mescaline: The forgotten psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Merlin Kirubakarababu, Arputharaj Samson Nesaraj (2022). \textit{Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective}. Indian Journal of Forensic Medicine \& Toxicology. [published; OpenAlex]. \href{https://doi.org/10.37506/ijfmt.v16i4.18608}{doi:10.37506/ijfmt.v16i4.18608}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ. (2022). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Odland AU, Kristensen JL, Andreasen JT. (2022). \textit{Animal Behavior in Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S (2022). \textit{The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30919}{doi:10.7759/cureus.30919}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M. (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item Barber GS, Aaronson ST. (2022). \textit{The Emerging Field of Psychedelic Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01363-y}{doi:10.1007/s11920-022-01363-y}.
\item Calder AE, Hasler G. (2022). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS. (2022). \textit{A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-022-00944-y}{doi:10.1007/s40263-022-00944-y}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9568164}{source link}.
\item Johannesdottir A, Sigurdsson E. (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Christensen JA, Fipps DC, Bostwick JM. (2022). \textit{To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.}. Experimental and Clinical Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000597}{doi:10.1037/pha0000597}.
\item Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. (2022). \textit{Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221116926}{doi:10.1177/02698811221116926}.
\item Neşe Devenot, Trey Conner, Richard Doyle (2022). \textit{Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12154}{doi:10.1111/anoc.12154}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. (2022). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. (2022). \textit{Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109214}{doi:10.1016/j.neuropharm.2022.109214}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Polito V, Liknaitzky P (2022). \textit{The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104706}{doi:10.1016/j.neubiorev.2022.104706}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ. (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Vorobyeva N, Kozlova AA. (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Inouye A, Wolfgang A. (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M. (2022). \textit{Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-022-01063-5}{doi:10.1007/s11916-022-01063-5}.
\item Knudsen GM. (2022). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Schindler EAD. (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item Felsch CL, Kuypers KPC. (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Fulmali A, Bharate SS. (2022). \textit{Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ddr.21953}{doi:10.1002/ddr.21953}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Jairaj C, Rucker JJ. (2022). \textit{Postpartum depression: A role for psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Henner RL, Keshavan MS, Hill KP. (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Sotille R, Singh H, Weisman A, Vida T. (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout (2022). \textit{An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus}. Frontiers in Forests and Global Change. [published; OpenAlex]. \href{https://doi.org/10.3389/ffgc.2022.813998}{doi:10.3389/ffgc.2022.813998}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD. (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS. (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Hayes C, Wahba M, Watson S. (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Rudzki S. (2022). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military Medicine. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Kisely S, Connor M, Somogyi AA, Siskind D. (2022). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Meade E, Hehir S, Rowan N, Garvey M. (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item van Amsterdam J, van den Brink W. (2022). \textit{The therapeutic potential of psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2047929}{doi:10.1080/14740338.2022.2047929}.
\item Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022). \textit{Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211069100}{doi:10.1177/02698811211069100}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. (2022). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP. (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK. (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Maia LO, Beaussant Y, Garcia ACM. (2022). \textit{The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpainsymman.2022.01.024}{doi:10.1016/j.jpainsymman.2022.01.024}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. (2022). \textit{Comment and Response: (Lugo-Radillo \& Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1983673}{doi:10.1080/02791072.2021.1983673}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Bender D, Hellerstein DJ. (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Russell J. Zwanka (2021). \textit{Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usage}. International Journal of Research in Marketing Management and Sales. [published; OpenAlex]. \href{https://doi.org/10.33545/26633329.2022.v4.i1a.88}{doi:10.33545/26633329.2022.v4.i1a.88}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2021). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Ehrmann K, Allen JJB, Moreno FA. (2021). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Agin-Liebes G, Davis AK. (2021). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Current topics in behavioral neurosciences. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Sousa TR, Rema J, Machado S, Novais F. (2021). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current Topics in Medicinal Chemistry. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. (2021). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. PubMed. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2021). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Plotnik L, Gibbs G, Graham T. (2021). \textit{Psilocybin Conspectus: Status, Production Methods, and Considerations.}. International journal of medicinal mushrooms. [published; Europe PMC]. \href{https://doi.org/10.1615/intjmedmushrooms.2021041921}{doi:10.1615/intjmedmushrooms.2021041921}.
\item Schindler EAD. (2021). \textit{Psychedelics in the Treatment of Headache and Chronic Pain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_365}{doi:10.1007/7854\_2022\_365}.
\item Flanagan TW, Nichols CD (2021). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW. (2021). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. (2021). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM. (2021). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item Elman I, Pustilnik A, Borsook D. (2021). \textit{Beating pain with psychedelics: Matter over mind?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Pearson C, Siegel J, Gold JA. (2021). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL. (2021). \textit{1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Whitfield HJ. (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A. (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Slocum ST, DiBerto JF, Roth BL. (2021). \textit{Molecular insights into psychedelic drug action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman (2021). \textit{Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.12.14}{doi:10.1176/appi.pn.2021.12.14}.
\item Ron Cole-Turner (2021). \textit{Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel12121058}{doi:10.3390/rel12121058}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. (2021). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M. (2021). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Radakovic C, Radakovic R, Peryer G, Geere J. (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yu7jf}{doi:10.31234/osf.io/yu7jf}.
\item Unknown authors (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yu7jf\_v1}{source link}.
\item Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS. (2021). \textit{Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.30773/pi.2021.0209}{doi:10.30773/pi.2021.0209}.
\item Barnett BS, Parker SE, Weleff J. (2021). \textit{United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103473}{doi:10.1016/j.drugpo.2021.103473}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Zeiss R, Gahr M, Graf H. (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Li NX, Hu YR, Chen WN, Zhang B. (2021). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T. (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Leger RF, Unterwald EM. (2021). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item de Vos CMH, Mason NL, Kuypers KPC. (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Lehto RH, Miller M, Sender J. (2021). \textit{The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.}. Journal of Holistic Nursing. [published; Europe PMC]. \href{https://doi.org/10.1177/08980101211039086}{doi:10.1177/08980101211039086}.
\item Kverno KS, Mangano E. (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Muthukumaraswamy SD, Forsyth A, Lumley T. (2021). \textit{Blinding and expectancy confounds in psychedelic randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2021.1933434}{doi:10.1080/17512433.2021.1933434}.
\item Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS (2021). \textit{Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab026}{doi:10.1093/ijnp/pyab026}.
\item Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla (2021). \textit{Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v10i10.19297}{doi:10.33448/rsd-v10i10.19297}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R. (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Waters K. (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. The Journal of Clinical Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M. (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. (2021). \textit{Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103380}{doi:10.1016/j.drugpo.2021.103380}.
\item Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić (2021). \textit{Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-021-00385-5}{doi:10.1007/s40429-021-00385-5}.
\item Horton DM, Morrison B, Schmidt J. (2021). \textit{Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.psychotherapy.20200055}{doi:10.1176/appi.psychotherapy.20200055}.
\item Nick Zagorski (2021). \textit{Psychedelic Therapy Hits Another Milestone, But Caution Urged}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.7.14}{doi:10.1176/appi.pn.2021.7.14}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Unknown authors (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Unknown authors (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. (2021). \textit{The Therapeutic Potential of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26102948}{doi:10.3390/molecules26102948}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Unknown authors (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Bird CIV, Modlin NL, Rucker JJH. (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A. (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Stanley N. Caroff (2021). \textit{The Return of Psychedelics: Still Time to Prevent Tragedy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.4.8}{doi:10.1176/appi.pn.2021.4.8}.
\item Zeifman RJ, Singhal N, Breslow L, Weissman CR. (2021). \textit{On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00024}{doi:10.1021/acsptsci.1c00024}.
\item Muthukumaraswamy S, Forsyth A, Lumley T. (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q2hzm}{doi:10.31234/osf.io/q2hzm}.
\item Unknown authors (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/q2hzm\_v1}{source link}.
\item Nick Zagorski (2021). \textit{Session on Psychedelics Sure to Be Enlightening}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.3.14}{doi:10.1176/appi.pn.2021.3.14}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K. (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Winkelman MJ. (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Bates MLS, Trujillo KA. (2021). \textit{Use and abuse of dissociative and psychedelic drugs in adolescence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2021.173129}{doi:10.1016/j.pbb.2021.173129}.
\item Barnett BS, Greer GR. (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item Mertens LJ, Preller KH. (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Healy CJ. (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Michael W. Dzierlenga (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Bryn T. M. Dentinger, Alexander J. Bradshaw (2020). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.58864.r95528}{doi:10.5256/f1000research.58864.r95528}.
\item Victor Lange, Marie, Sidsel (2020). \textit{Exploring moral bio-enhancement through psilocybin facilitated prosocial effects}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/f4c6737a-15ce-4a92-a7c5-ce5345cc1cff}{source link}.
\item Yogesh Kumar Chahar (2020). \textit{Unmet need in depression: Psilocybin, a breakthrough treatment option}. International Journal of Advanced Research in Medicine. [published; OpenAlex]. \href{https://doi.org/10.22271/27069567.2021.v3.i1f.159}{doi:10.22271/27069567.2021.v3.i1f.159}.
\item Jonas Bååth, Johan Nordgren (2020). \textit{Trip Reports: Exploring the Experience of Psychedelic Intoxication}. Lund University Publications (Lund University). [published; OpenAlex]. \href{https://doi.org/10.4324/9780429058141-26}{doi:10.4324/9780429058141-26}.
\item Inserra A, De Gregorio D, Gobbi G. (2020). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2020). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ (2020). \textit{Historic psychedelic drug trials and the treatment of anxiety disorders.}. Depression and anxiety. [published; PubMed]. \href{https://doi.org/10.1002/da.23065}{doi:10.1002/da.23065}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. (2020). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. (2020). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Lenz C, Sherwood A, Kargbo R, Hoffmeister D. (2020). \textit{Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cplu.202000581}{doi:10.1002/cplu.202000581}.
\item Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H. (2020). \textit{Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-33143/v2}{doi:10.21203/rs.3.rs-33143/v2}.
\item Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL. (2020). \textit{Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s003329172000389x}{doi:10.1017/s003329172000389x}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Ona G, Bouso JC. (2020). \textit{Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.09.035}{doi:10.1016/j.neubiorev.2020.09.035}.
\item Lawrence Silver (2020). \textit{Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship}. American Journal of Management. [published; OpenAlex]. \href{https://doi.org/10.33423/ajm.v20i3.3104}{doi:10.33423/ajm.v20i3.3104}.
\item Peter S. Hendricks (2020). \textit{Psilocybin-assisted group therapy: A new hope for demoralization}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100557}{doi:10.1016/j.eclinm.2020.100557}.
\item Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS. (2020). \textit{The emerging role of psilocybin and MDMA in the treatment of mental illness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2020.1826931}{doi:10.1080/14737175.2020.1826931}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML. (2020). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Vitkauskas M, Mathuru AS. (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L. (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Greif A, Šurkala M. (2020). \textit{Compassionate use of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-020-09958-z}{doi:10.1007/s11019-020-09958-z}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Kuypers KPC. (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item Vann Jones SA, O'Kelly A. (2020). \textit{Psychedelics as a Treatment for Alzheimer's Disease Dementia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnsyn.2020.00034}{doi:10.3389/fnsyn.2020.00034}.
\item Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL. (2020). \textit{Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2020.1794811}{doi:10.1080/17512433.2020.1794811}.
\item O'Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M. (2020). \textit{Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jmt/thaa006}{doi:10.1093/jmt/thaa006}.
\item James E, Robertshaw TL, Hoskins M, Sessa B. (2020). \textit{Psilocybin occasioned mystical-type experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.2742}{doi:10.1002/hup.2742}.
\item Hirschfeld T, Schmidt TT. (2020). \textit{How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.06.09.142802}{doi:10.1101/2020.06.09.142802}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Animal Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/handle/1974/27834}{source link}.
\item Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Therapy Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/jspui/handle/1974/27833}{source link}.
\item Ron Shore (2020). \textit{Psychedelics, Safety and Clinical Trial Design}. QSpace (Queen's University Library). [published; OpenAlex]. \href{http://hdl.handle.net/1974/27835}{source link}.
\item Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J. (2020). \textit{Psychedelic treatment of functional neurological disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320912125}{doi:10.1177/2045125320912125}.
\item Unknown authors (2020). \textit{Data justify further research on potential of psychedelics in treating psychiatric disorders}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30581}{doi:10.1002/pu.30581}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Heuschkel K, Kuypers KPC. (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK. (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Diseño interior. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Chi T, Gold JA. (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Brooke Reichenbach (2019). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2019). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Eric Vermetten, Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, Robert A. Schoevers, W van den Brink (2019). \textit{[Psychedelics in the treatment of PTSD].}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292}{source link}.
\item Grassi G, Cecchelli C, Vignozzi L, Pacini S. (2019). \textit{Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/jep.s255375}{doi:10.2147/jep.s255375}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR. (2019). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. (2019). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Begola MJ, Schillerstrom JE. (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item Muttoni S, Ardissino M, John C. (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG. (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. (2019). \textit{Psychedelic-Assisted Group Therapy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2019.1593559}{doi:10.1080/02791072.2019.1593559}.
\item Nick Zagorski (2019). \textit{Is Psychedelic Medicine on the Horizon?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.1b1}{doi:10.1176/appi.pn.2019.1b1}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS. (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Emma Christersson (2018). \textit{The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic Research}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255}{source link}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD. (2018). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Honyiglo E, Franchi A, Cartiser N, Bottinelli C, Advenier AS, Bévalot F, Fanton L. (2018). \textit{Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.13982}{doi:10.1111/1556-4029.13982}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Bayne T, Carter O. (2018). \textit{Dimensions of consciousness and the psychedelic state.}. Neuroscience of Consciousness. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niy008}{doi:10.1093/nc/niy008}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. International Review of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S. (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Barrett FS, Preller KH, Kaelen M (2018). \textit{Psychedelics and music: neuroscience and therapeutic implications.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1484342}{doi:10.1080/09540261.2018.1484342}.
\item Cameron LP, Olson DE. (2018). \textit{Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00101}{doi:10.1021/acschemneuro.8b00101}.
\item Geiger HA, Wurst MG, Daniels RN. (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Skryabin VY, Vinnikova M, Nenastieva A, Alekseyuk V. (2018). \textit{Hallucinogen persisting perception disorder: A literature review and three case reports.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10550887.2019.1673655}{doi:10.1080/10550887.2019.1673655}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Whelan A, Johnson MI. (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Kayla Wilwohl (2017). \textit{Are psychedelics effective in treating anxiety associated with a lifethreatening disease}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/308}{source link}.
\item Preller KH, Vollenweider FX (2017). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2017). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Barrett FS, Griffiths RR. (2017). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J. (2017). \textit{Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Swanson LR (2017). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S. (2017). \textit{Rapid-Acting Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Rucker JJH, Iliff J, Nutt DJ. (2017). \textit{Psychiatry \& the psychedelic drugs. Past, present \& future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.040}{doi:10.1016/j.neuropharm.2017.12.040}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Mason Marks (2017). \textit{Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3181777\_code2827981.pdf?abstractid=3065035\&mirid=1}{source link}.
\item Di Giovanni G, De Deurwaerdère P. (2017). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. (2017). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Larsen JK. (2017). \textit{LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.}. Nordic Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2017.1336251}{doi:10.1080/08039488.2017.1336251}.
\item Johnson MW, Griffiths RR. (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Feng LY, Battulga A, Han E, Chung H, Li JH (2017). \textit{New psychoactive substances of natural origin: A brief review.}. Journal of food and drug analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jfda.2017.04.001}{doi:10.1016/j.jfda.2017.04.001}.
\item Janis Phelps (2017). \textit{Developing Guidelines and Competencies for the Training of Psychedelic Therapists}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817711304}{doi:10.1177/0022167817711304}.
\item Thomas K, Malcolm B, Lastra D. (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Dinis-Oliveira RJ. (2017). \textit{Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03602532.2016.1278228}{doi:10.1080/03602532.2016.1278228}.
\item Henry A. Nasrallah (2016). \textit{Maddening Therapies: How Hallucinogens Morphed into Novel Treatments}. Current psychiatry. [published; OpenAlex]. \href{https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into}{source link}.
\item Kraehenmann R. (2016). \textit{Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1573413713666170619092629}{doi:10.2174/1573413713666170619092629}.
\item Daniel J, Haberman M. (2016). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. Mental Health Clinician. [published; Europe PMC]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Bobby Lazzara (2016). \textit{Psilocybin to Manage Cancer-Related Depression}. Unknown journal. [published; OpenAlex]. \href{https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression}{source link}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Jeanne G, Purper-Ouakil D, Rigole H, Franc N. (2016). \textit{[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2016.05.012}{doi:10.1016/j.encep.2016.05.012}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Tófoli LF, de Araujo DB. (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Lowe LM, Peterson BL, Couper FJ. (2015). \textit{A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkv092}{doi:10.1093/jat/bkv092}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Baumeister D, Tojo LM, Tracy DK. (2015). \textit{Legal highs: staying on top of the flood of novel psychoactive substances.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125314559539}{doi:10.1177/2045125314559539}.
\item Bogenschutz MP, Johnson MW. (2015). \textit{Classic hallucinogens in the treatment of addictions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Steeds H, Carhart-Harris RL, Stone JM (2015). \textit{Drug models of schizophrenia.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314557797}{doi:10.1177/2045125314557797}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS. (2014). \textit{Recreational use, analysis and toxicity of tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Halberstadt AL. (2014). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Charlesice Hawkins (2013). \textit{Literature review: Considerations for Psychedelic Research}. UC Merced Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/m451020759}{doi:10.5070/m451020759}.
\item Tylš F, Páleníček T, Horáček J. (2013). \textit{Psilocybin--summary of knowledge and new perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Icaza EE, Mashour GA. (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; Europe PMC]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Halberstadt AL, Geyer MA. (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Stebelska K. (2013). \textit{Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0b013e31828741a5}{doi:10.1097/ftd.0b013e31828741a5}.
\item Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB. (2013). \textit{Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0064646}{doi:10.1371/journal.pone.0064646}.
\item Bogenschutz MP. (2013). \textit{Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/15733998113099990002}{doi:10.2174/15733998113099990002}.
\item Hanks JB, González-Maeso J. (2012). \textit{Animal models of serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Carod-Artal FJ. (2011). \textit{Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nrl.2011.07.003}{doi:10.1016/j.nrl.2011.07.003}.
\item van Amsterdam J, Opperhuizen A, van den Brink W (2011). \textit{Harm potential of magic mushroom use: a review.}. Regulatory toxicology and pharmacology: RTP. [published; PubMed]. \href{https://doi.org/10.1016/j.yrtph.2011.01.006}{doi:10.1016/j.yrtph.2011.01.006}.
\item Sun-Edelstein C, Mauskop A. (2011). \textit{Alternative headache treatments: nutraceuticals, behavioral and physical treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1526-4610.2011.01846.x}{doi:10.1111/j.1526-4610.2011.01846.x}.
\item Halberstadt AL, Geyer MA. (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Barbee G, Berry-Cabán C, Barry J, Borys D, Ward J, Salyer S. (2009). \textit{Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03161087}{doi:10.1007/bf03161087}.
\item González-Maeso J, Sealfon SC. (2008). \textit{Agonist-trafficking and hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD. (2008). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Geyer MA, Vollenweider FX. (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item Hermle L, Kovar KA, Hewer W, Ruchsow M. (2008). \textit{[Hallucinogen-induced psychological disorders].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2008-1038191}{doi:10.1055/s-2008-1038191}.
\item Frecska E, Luna LE. (2006). \textit{The adverse effects of hallucinogens from intramural perspective.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17211054}{source link}.
\item Rimsza ME, Moses KS. (2005). \textit{Substance abuse on the college campus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pcl.2004.10.008}{doi:10.1016/j.pcl.2004.10.008}.
\item Halpern JH. (2004). \textit{Hallucinogens and dissociative agents naturally growing in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2004.03.003}{doi:10.1016/j.pharmthera.2004.03.003}.
\item Nielen RJ, van der Heijden FM, Tuinier S, Verhoeven WM. (2003). \textit{Khat and mushrooms associated with psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15622970410029908}{doi:10.1080/15622970410029908}.
\item Carod Artal FJ. (2003). \textit{[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.33588/rn.3610.2003019}{doi:10.33588/rn.3610.2003019}.
\item Gross ST. (2002). \textit{Psychotropic drugs in developmental mushrooms: a case study review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs15564j}{doi:10.1520/jfs15564j}.
\item Passie T, Seifert J, Schneider U, Emrich HM. (2002). \textit{The pharmacology of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Moeller MR, Kraemer T. (2002). \textit{Drugs of abuse monitoring in blood for control of driving under the influence of drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00007691-200204000-00003}{doi:10.1097/00007691-200204000-00003}.
\item Vollenweider FX. (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vetulani J. (2001). \textit{Drug addiction. Part I. Psychoactive substances in the past and presence.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11785921}{source link}.
\item Salomé F, Boyer P, Fayol M. (2000). \textit{The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0924-9338(00)00520-4}{doi:10.1016/s0924-9338(00)00520-4}.
\item Pierrot M, Josse P, Raspiller MF, Goulmy M, Rambourg MO, Manel J, Lambert H. (2000). \textit{[Intoxications by hallucinogenic mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11104939}{source link}.
\item McBride MC. (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Drummer OH. (1999). \textit{Chromatographic screening techniques in systematic toxicological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(99)00265-0}{doi:10.1016/s0378-4347(99)00265-0}.
\item Hughes JR. (1995). \textit{A review of the usefulness of the standard EEG in psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/155005949602700106}{doi:10.1177/155005949602700106}.
\item Chamakura RP. (1994). \textit{Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26270149}{source link}.
\item Riedlinger TJ. (1993). \textit{Wasson's alternative candidates for soma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1993.10472245}{doi:10.1080/02791072.1993.10472245}.
\item Gable RS. (1992). \textit{Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00952999309001618}{doi:10.3109/00952999309001618}.
\item Lassen JF, Ravn HB, Lassen SF. (1989). \textit{[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2301080}{source link}.
\item Leikin JB, Krantz AJ, Zell-Kanter M, Barkin RL, Hryhorczuk DO. (1989). \textit{Clinical features and management of intoxication due to hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03259916}{doi:10.1007/bf03259916}.
\item Schwartz RH, Smith DE. (1988). \textit{Hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/000992288802700202}{doi:10.1177/000992288802700202}.
\item J. Francis, Virginia Murray (1983). \textit{Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981}. Human Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1177/096032718300200229}{doi:10.1177/096032718300200229}.
\item Peden NR, Pringle SD, Crooks J. (1982). \textit{The problem of psilocybin mushroom abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/096032718200100408}{doi:10.1177/096032718200100408}.
\item McDonald A. (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Green JP, Weinstein H, Maayani S. (1977). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/30911}{source link}.
\item J.E. Kleinman, J. Christian Gillin, Richard Jed Wyatt (1976). \textit{A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*}. Schizophrenia Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1093/schbul/3.4.560}{doi:10.1093/schbul/3.4.560}.
\item Unknown authors (1966). \textit{Review of Drugs and Phantasy: The Effects of LSD, Psilocybin, and Sernyl on College Students.}. Contemporary Psychology. [published; OpenAlex]. \href{https://doi.org/10.1037/008835}{doi:10.1037/008835}.
\item Vargas Ibarra, Pablo (n.d.). \textit{Spiritual dimension and psychedelic experiences: A phenomenological approach}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/VARSDA}{source link}.
\end{enumerate}
\end{document}
